As Medtronic prepares to seek FDA approval for an artificial pancreas, many have wondered why it’s taken so long to get to this point. A recent study suggests that might be because the FDA may be slower to approve medical devices than drugs, according to a report by Mass Device.
GLP-1 Victoza reduces the risk of death from heart disease, kidney disease, hypoglycemia, severe hypoglycemia, and other complications in people with type 2 diabetes at high risk for heart disease.
Unfortunately, researchers are finding that people with one autoimmune condition are prone to others. For example, a recent study has found that people with celiac disease and Type 1 diabetes have a higher risk of also developing autoimmune thyroid disease.
Drugs used to treat diabetes could also be used to treat Alzheimer’s disease, and vice versa, according to new research. This is also the first study of its kind to show that Alzheimer’s disease can lead to diabetes, as opposed to diabetes occurring first as was previously thought.
Having diabetes increases the risk of dying from the effects of a heart attack by around 50 percent, according to a widespread study. The study’s participants with diabetes were 39 per cent more likely to have died if they had a non-ST elevation myocardial infarction (NSTEMI) heart attack — in which the artery is partially […]
In a new study, researchers found that Android-based diabetes apps sometimes collect private health data and share it with outside third parties without warning users. Researchers with the Illinois Institute of Technology Chicago-Kent College of Law found that 81 percent of the 211 Android-based diabetes apps reviewed did not have privacy policies. Only four of […]
While general advice on how to improve diet to reduce diabetes symptoms and obesity can work, researchers in a recent study found a personalized, specific nutrition plan was far more effective for achieving health goals. Researchers at the Joslin Diabetes Center found structured nutrition therapy helped patients reach health goals similar to those of medications […]
The FDA just released details on the July 21 Advisory Panel hearing on whether Dexcom’s G5 CGM should be officially approved for dosing insulin. The meeting is open to the public, and anyone interested can (i) submit a written comment to the FDA; (ii) attend the meeting; and (iii) request to give an oral presentation […]
The Eversense CGM uses a 90-day implanted sensor that is placed in the upper arm in a 5-10 minute in-office procedure. A rechargeable transmitter device is worn on top of the skin, directly over the sensor, which powers the implant and sends the current glucose value and trend arrow to a smartphone. The transmitter is […]
People with type 2 diabetes who intensively controlled their blood sugar level during the landmark ACCORD Trial Eye Study were found to have cut their risk of diabetic retinopathy in half in a follow-up analysis conducted four years after stopping intensive therapy.
Pharma companies are testing whether drugs designed for combatting Type 2 diabetes can be used to also treat Type 1 diabetes. The latest attempt involves a class of of oral antidiabetics called SGLT2 inhibitors, first cleared by the Food and Drug Administration on March 29, 2013.
Google made some big promises about how it would cure what ails us, but now it looks like we may never get those diabetes-detecting contact lenses or that FitBit-like cancer-detection wearable.
Until very recently, shots were the only way to administer insulin. But an inhalable version of this life-sustaining drug has been in the works for decades, and has recently come to market — yet its fate still hangs in the air.
Why the FDA may change its definition of healthy, and how it could impact people with diabetes. Plus, what’s coming to nutrition labels?
Dozens of weight loss studies show that participants can experience initial success when it comes to losing weight, but over the course of five years (or even just one year), many struggle to maintain that level of weight loss.
Everyone with Type 1 diabetes at one time or another has had a bad low, the kind when all you want to do is eat everything in sight. There’s no reasoning with yourself – it’s as if someone has hijacked your self-control.
Type 2 diabetic patients who took both insulin and metformin showed a reduced risk of death and cardiac events compared with people treated with insulin alone, according to a new study conducted by researchers at Cardiff University.
The long-term, “best case scenario” idea of the “perfect” smart insulin is very compelling for people with diabetes on insulin: one injection per day, blood sugar levels that stay in zone without hypoglycemia, no more carb counting, no more guessing what dose is correct, no more feeling frightened, and a much safer and less stressful […]
Consuming junk food can cause high blood sugar levels and the same amount of harm to the kidneys as type 2 diabetes, according to a new study published in Experimental Physiology.
A new study on life expectancy and Type 1 diabetes has brought results that can be seen as glass half-empty or glass half-full. The bad news is that life expectancy for people with Type 1 is still shorter than that of the average population; the good news is that people with Type 1 are living […]